MARKET OPPORTUNITY
Global market · $50B
REGULATORY INTELLIGENCE
Regulation & market access
CAPITAL & VALUATION
Public & private markets
EMERGING MARKETS
Clinical pipelines
RESEARCH & DEVELOPMENT
Science to strategy
Decision intelligence // Cannabis // Psychedelics // Novel compounds
From our offices in Toronto, Zurich and Amsterdam, we help governments, financial institutions and global enterprises turn cannabis, psychedelics and novel-compound intelligence into informed decisions.
Deep cannabis expertise. Proprietary intelligence. Best in class analysis.
An experienced cannabis team and a proprietary database — connecting market evidence, policy insight and strategic judgment.
Market intelligence / Basket view
An equal-weight snapshot of our listed coverage universe — cannabis, psychedelics and adjacent businesses. Historical returns, recorded dividends and reported earnings.
Retrieving historical prices and financial statements…
Independent, evidence-led intelligence — for the people whose decisions make headlines.
Rigorous valuation and risk modelling of listed and pre-IPO companies across cannabis, psychedelic and novel-compound markets.
Bespoke intelligence reports on regulatory trajectories, market structure, clinical pipelines and capital flows.
Closed-door briefings and scenario workshops for ministries, legislators and regulators shaping policy.
Board-level counsel for banks and corporations evaluating exposure, compliance and market entry.